|
PHIND, the Pharmaceutical and Healthcare Industry News Database,
produces up-to-date intelligence about product developments,
markets, regulatory affairs and other matters of importance to the
international pharmaceutical, medical device, veterinary and
agrochemical industries.
PHIND contains pre-publication, current and archival material from
major industry newsletters:
- Scrip - World Pharmaceutical News;
- Clinica - World Medical Device and Diagnostic News;
- Animal Pharm - World Animal Health and Nutrition News;
- Agrow - World Crop Protection News;
- ASI - Agricultural Supply Industry News;
- EURALex (previously ERA News) - European Regulatory Affairs News;
- China News File - Chinese Pharmaceutical Industry News);
- Bioventure View (incorporating GenomiKa) - Biotech Industry News
(archive only);
- Instrumenta;
- Target - World Drug Delivery News.
- Healthcare Lobbyist (new, June 2005)
The full text of all reports appears in the daily and current
databases within three working days of writing. Each report has been
written on the basis of news gathered from a wide variety of sources
including direct briefings, scientific and trade publications,
annual reports, brokers' reports, press releases, and meetings. All
the range of information available is evaluated for relevance to the
major industrial areas covered and is amplified by investigative
reporting.
The database also contains the PJB Source Online Plus, which
includes statistical market data and other analytical information
not necessarily found in the published magazines.
Use PHIN to:
- retrieve all 'Scrip' articles from the daily (PHID) file
- retrieve articles discussing AIDS treatment and possible side
effects
- find articles discussing developments for anticancer agents in the
US
- find recent articles on Glaxo SmithKline & French sales
Sources:
Daily news
SCRIP World Pharmaceutical News - published twice weekly SCRIP is
widely recognised for its balanced and authoritative coverage of
political and market trends, financial news, regulatory affairs and
new product developments in the international pharmaceutical
industry.
CLINICA World Medical Technology News - published weekly CLINICA
provides the latest news on emerging markets, new technologies,
company news, regulatory developments, meetings and business
opportunities around the world.
ANIMAL PHARM World Animal Health News - published twice monthly,
this provides coverage of all key industry developments. Including
politics, legislation and regulatory affairs; company, product and
R&D news; livestock disease incidence; market trends; and reports on
the latest conferences.
AGROW World Crop Protection News - published twice monthly, AGROW
reports on company news and performance, market trends and data, the
latest product R&D, regulatory affairs, environmental and political
issues, plus forthcoming conferences.
Weekly news
ASI Agricultural Supply Industry - published weekly, is the
industry's leading trade newsletter. ASI provides in-depth news,
analysis and insight into UK agribusiness and its EU interface. The
newsletter covers; political and economic developments, feeds, grain
trading, fertilisers, animal health products and new equipment.
Monthly news
EURALex (previously ERA News) - European Regulatory Affairs News -
published monthly, EURALex provides concise and accurate coverage
of EU regulatory affairs affecting the human and veterinary
pharmaceutical and medical device industries.
THE HEALTHCARE LOBBYIST - published monthly, THE HEALTHCARE LOBBYIST
provides the reader with articles that raise awareness of lobbying
and eductes them on how governments work and the extent to which
political lobbyists can influence healthcare policy.
INSTRUMENTA (previously All Report) - provides unmatched insight
into trends and developments in the analytical instruments and
laboratory equipment market.
TARGET- Target World Drug Delivery News - focuses on the
international drug delivery industry, with coverage of technologies
and products from research to launch, patents, agreements, licensing
opportunities, and business and finance.
BIOVENTURE VIEW (incorporating GenomiKa) - published monthly
BIOVENTURE VIEW not only provides coverage of news events in the
biotechnology industry, but also insights, analyses, and opinions to
give readers a perspective on the sector that other industry
periodicals do not provide. As of 12 August 2003, Bioventure View
also incorporates the GenomiKa newsletter (see below).
ONLINE PLUS
Online Plus provides additional articles which do not appear in any
printed newsletter. It also includes summaries of new product
launches and new drug registration from the weekly updates to the
Pharmaprojects database.
Annual newsletter reviews for Scrip, Clinica, Animal Pharm World
Animal Health and Nutrition News, and Agrow are also available,
providing reports on the key issues which affected the industry in
the previous year. The reviews also include company league tables
and a conference calendar for the current year.
ARCHIVE ONLY
The following newslatter sources are available as archive only:
BioVenture View, GenomiKa, EPLC - European Pharma Law centre (now
EURALEX), SCRIP OTC News, Outcomes World Health Economics News,
China News-File.
Note that as of September 1995, company profile documents have no
longer been updated in the PHIN database and E-MED-NEWS ceased
publication from February 1997.
Accession number & update
S01003106 20080702.
Title
Bayer acquires Maxygen and Topsun portfolios (F).
Source
Scrip.
Publication date
20080702.
Text
Bayer Healthcare has acquired a haemophilia product programme
from Maxygen and a cough and cold portfolio from Topsun
Science and Technology.
Maxygen's haemophilia programme includes the recombinant
Factor VIIa protein, Maxy-VII, which is expected to enter
Phase I clinical trials this year. Bayer will pay Maxygen $90
million upfront and a possible $30 million in milestone
payments. The agreement includes a licence for Bayer to use
Maxygen's molecular breeding technology for exploiting gene
targets and Bayer will receive exclusive rights to use the
technology for 30 specified gene targets in areas of strategic
business interest.
Maxy-VII has the potential to become the world's first
approved shuffled protein drug, and is likely to open up more
opportunities for the smaller US-based Maxygen, Russell
Howard, CEO of the company, said.
Bayer Healthcare has also acquired the Western OTC cough and
cold portfolio of Topsun Science and Technology for Rb1
billion ($156 million) as well as contingent payments of Rb192
million, subject to the fulfilment of certain performance
criteria. The portfolio, which includes brands such as White &
Black, reported Rb331 million in 2005 sales, the firms say.
The staff and assets related to the portfolio, including the
Gaitianli manufacturing facility in Qidong City, China, and
the national sales and distribution network associated with
the brands, will transfer to Bayer Healthcare and operate
within its consumer care division. SCRIP - World
Pharmaceutical News - www.scrippharma.com FILED 02 July 2008
COPYRIGHT Informa UK Ltd 2008.
Label/description Example
AN Accession Number 1_: S01003106.AN.
& update 2_: 20080702.AN.
TI Title 3_: BAYER WITH
MAXYGEN.TI.
SO Source 4_: SCRIP.SO.
DT Publication Date 5_: 20080702.DT.
- see Notes below - 6_: DATE=20080702
7_: MONTH=200807
8_: YEAR=2008
TX Text 9_: BAYER WITH MAXYGEN.TX.
Brief articles 10_: TI=B
Full, substantial articles 11_: TI=F
'Untitled' articles (title is not
meaningful enough to convey
content) 12_: TI=U.
1_: LIVESTOCK ADJ FEED
DATE Publication date YYYYMMDD 2_: ..L 1 DATE>20080315
MONTH Publication month YYYYMM 3_: ..L 1 MONTH>200803
YEAR Publication year YYYY 4_: ..L 1 YEAR=2008
UDATE Update date YYYYMMDD 5_: ..L 1 UDATE>20071130
UMONTH Update month YYYYMM 6_: ..L 1 UMONTH>200711
By paragraph - title, text _: ..P TI, TX 1-5
SHORT AN OC TI SO DT
MEDIUM AN OC TI SO DT TX
LONG AN OC TI SO DT TX
ALL AN OC TI SO DT TX
KWIC Context of search terms from TX paragraph
HITS All paragraphs where search terms occur
FREE AN OC TI
_: ..P LONG 1,2-4.
DT - Publication date:
This date refers to the date that the document was added by PJB to
their own computer database. It does not refer to the date on which
the docuemnt was published in hard-copy.
Full text searching in PHIN:
Searching in TX paragraphs:
Link your search terms using WITH (same sentence) and SAME (same TX
paragraph) operators for relevance of retrieval.
Searching PHID, PHIC and PHIN:
Use PHID for daily scanning of reports on topics of particular
interest, PHIC for recently written reports and PHIN for
retrospective searching. If you need ALL information on a particular
topic you must search both PHIN and PHIC. You can use ..REPEAT to
facilitate this
- In PHIN -
1_: LIVESTOCK WITH PRICES
RESULT 75
2_: ..REPEAT PHIC
PROCESSING OF DATABASES BEING PREPARED, PLEASE WAIT.
- In PHIC -
2_: LIVESTOCK WITH PRICES
RESULT 3
Search Options:
..SET PLURALS ON and ..SET MEDWORD ON can be selected in PHIN.
Terms and conditions
TERMS AND CONDITIONS FOR THE DOWNLOADING AND ELECTRONIC STORAGE
AND/OR DISTRIBUTION OF DATA FROM THE PJB PUBLICATIONS LTD
ELECTRONIC NEWS AND INFORMATION DATABASES AS FOLLOWS BUT NOT
LIMITED TO: PHID PHIC, PHIN, PHCO, PHAR, PHAB, PHAX, PHAZ, PHLP,
PHAP, PHZZ, PHID, PHAR-THERA, PHAR-COMP AND DIALOG FILES
128,928,129,130 AND 131
PJB Publications Ltd, in common with other publishers wishes to
protect against infringement of its copyright and the conditions
of use of its databases while allowing fair use of material
supplied to its customers. PJB requires payment of a fair and
reasonable licence fee for use which is not covered by Category 1.
CATEGORY 1 (No licence required)
The following is allowed without permission or charge:
1. Online users of PJB online databases may download data from
those databases onto a personal computer (PC) or into their
personal electronic mailbox and integrate that information into a
computer file held on that PC.
2. Members of staff of the customer organisation at the customer
location where the PJB data is downloaded may examine the
computer file holding that data, provided that this is done at
the PC on which it is held.
3. Information downloaded onto a receiving PC may be moved to
another PC located at the customer location, provided the PJB
data is held on only one (1) PC and is accessible only at that PC.
4. Permission is granted to make one (1) electronic copy of the
downloaded PJB data for back-up security purposes to be used only
if the first copy becomes unusable.
5. Online users may make occasional printed hard copies of the
downloaded PJB data and this hardcopy may be examined by members
of the customer organisation working at the customer location
where the downloading took place. The hardcopy may be kept for
reference in a central location such as a library at the customer
location where downloading took place. Additional copying of this
hardcopy is in breach of the copyright of PJB Publications Ltd.
6. The downloaded PJB data is restricted to employees of the
customer and may not be exploited whether by way of sale, licence
or otherwise to any third party.
7. It is a condition of usage within Category 1 that PJB data may
only be held in electronic form for a maximum period of 60 days
from the date it is first downloaded and must then be deleted.
Please contact PJB Publications if you require further
information.
Back to the Datasheet Index Page
© 2008 Dialog DataStar
|